Summary
Axon Enterprise, Inc. (AXON), formerly TASER International, Inc., reported a net income of $1.14 million for the third quarter of 2011, a significant turnaround from a net loss of $2.34 million in the same period of the previous year. This improvement was driven by a 15.6% increase in net sales, reaching $24.4 million, primarily due to stronger domestic law enforcement sales and the introduction of the new TASER X2. Despite increased research and development expenses and a substantial litigation judgment expense, the company managed to improve its gross margin to 53.7% and reduce its SG&A expenses as a percentage of sales. For the first nine months of 2011, the company reported a net loss of $1.14 million, an improvement from a net loss of $4.19 million in the prior year period. Net sales grew by 7.3% to $68.7 million. The company generated positive cash flow from operations of $14.6 million, a notable shift from a negative $2.4 million in the prior year, supported by operational improvements and effective working capital management. However, a significant litigation judgment expense of $3.3 million and an asset impairment charge of $1.4 million impacted the year-to-date results.
Financial Highlights
47 data points| Revenue | $24.38M |
| Cost of Revenue | $11.28M |
| Gross Profit | $13.10M |
| R&D Expenses | $2.36M |
| SG&A Expenses | $9.48M |
| Operating Income | $1.21M |
| Net Income | $1.14M |
| EPS (Basic) | $0.02 |
| EPS (Diluted) | $0.02 |
| Shares Outstanding (Basic) | 58.79M |
| Shares Outstanding (Diluted) | 60.04M |
Key Highlights
- 1The company achieved profitability in the third quarter of 2011, reporting a net income of $1.14 million, a substantial improvement from a net loss of $2.34 million in Q3 2010.
- 2Net sales increased by 15.6% to $24.4 million in Q3 2011, driven by strong domestic law enforcement sales and the introduction of the new TASER X2.
- 3Gross margin improved significantly to 53.7% in Q3 2011, up from 49.4% in Q3 2010, indicating better cost management and product mix.
- 4For the nine months ended September 30, 2011, net cash provided by operating activities was $14.6 million, a marked improvement from a net cash used of $2.4 million in the same period of 2010.
- 5The company reported a substantial litigation judgment expense of $3.3 million in Q2 2011 related to the Turner case, impacting profitability for the nine-month period.
- 6An asset impairment charge of $1.4 million was recorded in Q2 2011 related to the abandonment of the Protector product line.
- 7TASER repurchased approximately $24.9 million of its common stock in the first nine months of 2011 under its authorized repurchase programs.